Stockscreener 앱 받기
2.37
0.00%
0.00
시간 외 거래:
2.38
0.010
+0.42%
전일 마감가:
$2.37
열려 있는:
$2.37
하루 거래량:
49,738
Relative Volume:
0.04
시가총액:
$21.28M
수익:
$93.76M
순이익/손실:
$-13.68M
주가수익비율:
-0.9011
EPS:
-2.63
순현금흐름:
$8.77M
1주 성능:
-1.25%
1개월 성능:
+1.28%
6개월 성능:
+52.90%
1년 성능:
-1.66%
1일 변동 폭
$2.3493
$2.42
1주일 범위
$2.30
$2.82
52주 변동 폭
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
명칭
Aytu Biopharma Inc
전화
(720) 437-6580
주소
7900 E. UNION AVENUE, DENVER
AYTU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.37 | 21.81M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 개시 | Lake Street | Buy |
| 2025-06-30 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-29 | 개시 | H.C. Wainwright | Buy |
Aytu Biopharma Inc 주식(AYTU)의 최신 뉴스
Risk adjusted return profile for Aytu BioPharma Inc. analyzedPattern Recognition Tool for ROI Investors - Newser
Live market analysis of Aytu BioPharma Inc.Support and Resistance Zone Summary Chart - Newser
How hedge fund analytics apply to Aytu BioPharma Inc. stockAI Powered Buy Point Forecast Planner - Newser
What recovery options are there for Aytu BioPharma Inc.High Yield Signals with Entry Timing - Newser
Full technical analysis of Aytu BioPharma Inc. stockGrowth Watchlist for Long Term Positioning - Newser
Aytu BioPharma Inc. stock retracement – recovery analysisInsider Strategy for High Conviction Picks - Newser
What makes Aytu BioPharma Inc. stock price move sharplyCapitalize on market shifts with expert advice - Jammu Links News
What are the latest earnings results for Aytu BioPharma Inc.Exceptional trading results - Jammu Links News
What are analysts’ price targets for Aytu BioPharma Inc. in the next 12 monthsInvest smarter with advanced market data - Jammu Links News
How does Aytu BioPharma Inc. compare to its industry peersGet real-time alerts on high-potential stocks - Jammu Links News
Does Aytu BioPharma Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
Should I hold or sell Aytu BioPharma Inc. stock in 2025Capitalize on momentum-driven investment opportunities - Jammu Links News
Is it the right time to buy Aytu BioPharma Inc. stockInvest confidently with real-time data - Jammu Links News
What are Aytu BioPharma Inc. company’s key revenue driversSuperior investment outcomes - Jammu Links News
Is Aytu BioPharma Inc. a good long term investmentUnlock steady growth with low-risk stocks - Jammu Links News
Is Aytu BioPharma Inc. a growth stock or a value stockFree Real-Time Stock Data - Jammu Links News
Aytu BioPharma Inc. Stock Analysis and ForecastGet daily updates on top-performing stocks - Jammu Links News
When is Aytu BioPharma Inc. stock expected to show significant growthBuild wealth faster with professional insights - Jammu Links News
Evaluating Aytu BioPharma Inc. with trendline analysisPre-Market Stock Movement Summary and Review - Newser
What the charts say about Aytu BioPharma Inc. todayDownside Control Plan With Support Analysis - Newser
Can trapped investors hope for a rebound in Aytu BioPharma Inc.Predictive System for Long-Term Stock Forecast - Newser
Should I buy Aytu BioPharma Inc. stock before earningsDaily Market Entry Strategy with Tools - Newser
Multi asset correlation models including Aytu BioPharma Inc.Short Term Opportunity Finder with Tools - Newser
Will Aytu BioPharma Inc. outperform the marketWeekly Portfolio Update with ROI Focus - Newser
Combining price and volume data for Aytu BioPharma Inc.Free Top Gaining Picks With Entry Signals - Newser
Barclays Reiterates Sell Rating on Galapagos, Sets €22 Price Target - AInvest
Can technical indicators confirm Aytu BioPharma Inc.’s reversalFree Accurate Technical Trend Reversal Picks - Newser
Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition - MSN
Aytu BioPharma Inc. Stock Performance After Earnings: Historical InsightsReal-Time AI Sentiment and Price Forecast - Newser
Published on: 2025-07-30 02:06:07 - Newser
Why Aytu BioPharma Inc. stock attracts strong analyst attentionFree Reliable Alerts for Daily Stock Movers - Newser
Improved Revenues Required Before Aytu BioPharma, Inc. (NASDAQ:AYTU) Stock's 25% Jump Looks Justified - simplywall.st
What is Aytu BioPharma Inc. company’s growth strategyInvest confidently with professional guidance - Jammu Links News
Will Aytu BioPharma Inc. outperform the market Free Breakout Entry Signal Confirmation Tool - Newser
How volatile is Aytu BioPharma Inc. stock compared to the marketConsistent high-performance stocks - jammulinksnews.com
Published on: 2025-07-28 02:21:07 - jammulinksnews.com
Aytu Biopharma Inc (AYTU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):